The Global HPAPI Summit
for Pharma Leaders
Two intensive days in Rome on containment, regulatory compliance, CDMO partnership and sustainable high-potency manufacturing.
Where the HPAPI
Industry Meets
The 3rd Annual MaxPotent Pharma Summit is the international meeting point for Highly Potent Active Pharmaceutical Ingredients, bringing senior executives, regulatory authorities, technology providers and pharmaceutical innovators into one room.
Ten agenda themes, 23+ sessions and 60+ companies represented to date. Two intensive days on EU and global regulatory frameworks, containment and isolation technology, automation and process engineering, occupational health and safety, scale-up, and supply chain resilience.
150+ senior professionals and 20+ industry experts, in Rome, on 21–22 April 2027. A focused, high-density summit built to deliver real commercial and industry value, with particular emphasis on CDMO and CMO partnership models and sustainability in high-potency operations.
Why this programme is different
Our team of producers and analysts invests over a year of preparation to study market dynamics, regulatory changes, and upcoming innovations. This invite-only summit is designed exclusively for HPAPI professionals who want to stay ahead of industry trends and strengthen their expertise. It is the essential platform for knowledge exchange, career advancement, and shaping the future of high-potency drug development.
More about the summitWhat the 2027 Programme Covers
Ten themes shape the two-day agenda, from EU regulatory frameworks to digital twins on the shop floor.
Evolving EU Regulatory Frameworks
Adapting to the latest EMA and ECHA requirements to ensure compliance in HPAPI production.
Innovative Containment Technologies
Designing next-generation facilities with advanced isolators and fully closed systems.
Building Supply Chain Resilience
Addressing challenges in sourcing, logistics, and cross-border disruptions affecting HPAPIs.
Harnessing AI and Machine Learning
Driving precision manufacturing through real-time analytics and process analytical technologies (PAT).
Protecting Workforce & Operations
Applying robust risk assessment methods to safeguard operators and minimise exposure risks.
Sustainability in HPAPI Manufacturing
Reducing environmental impact through waste management and alignment with EU Green Deal goals.
Six Reasons to Be in Rome
Master EU Regulatory Compliance
Understand the latest EMA and ECHA directives shaping HPAPI manufacturing, containment, and transport.
Advance Containment Excellence
Examine state-of-the-art facility designs, isolator systems, and closed technologies that safeguard operators while boosting efficiency.
Transform Manufacturing with AI & Automation
See how robotics, machine learning, and Process Analytical Technology (PAT) are redefining high-potency drug production.
Build Resilient Supply Chains & CDMO Alliances
Explore strategies for outsourcing, risk management, and reinforcing supply chain continuity across Europe.
Drive Sustainability in HPAPI Manufacturing
Implement greener practices in waste reduction, resource efficiency, and regulatory-aligned eco strategies.
Learn from Real-World Leaders
Gain practical insights through case studies and direct engagement with senior pharma executives, regulators, and innovators.
Built for the Entire HPAPI Value Chain
Four groups meet in the same room for two days, and each one needs the other three.
Pharma & Biotech
R&D Directors, VP Manufacturing, Heads of Regulatory Affairs, CMC Leads
CMOs & CDMOs
Contract manufacturing leaders specialising in HPAPI handling, containment, and scale-up
Regulatory & EHS
EMA/ECHA compliance teams, occupational health scientists, risk assessment specialists
Tech & Equipment
Containment system vendors, isolator manufacturers, automation & PAT technology providers
Who Will Be in the Room
Based on the delivered Milan editions. The Rome edition is expected to match and exceed these benchmarks.
Audience by sector
Seniority breakdown
The Industry You Operate in Is Growing Fast
Projected market value driven by oncology, ADCs, and precision medicine demand
One of the fastest-growing segments across the global pharmaceutical industry
High-potency compounds now dominate oncology drug development pipelines globally
Active compounds in clinical and pre-clinical development requiring specialist expertise
Planned CDMO and containment facility investments across Europe over the next 5 years
Reported increase in occupational exposure events underscoring urgency of better containment
Experts Who Have Taken Our Stage
Speakers and advisors from across the 2027 editions.
Ester Lovsin Barle
Global Head Product Sustainability and Stewardship
Takeda
Luiz Alberto Barberini
Head, External Manufacturing, Latin America
Bayer
Jana Nunić
Senior Occupational Toxicologist
Novartis
Silke Büchl
CEO
Praevena AG
Carla Landolfi
CEO & Founder
ToxHub Srl
Michael Dekner
Aseptic BioProcessing, Biotechnology, Innovation & External Collaboration Expert
Jeremy Wien
Containment Expert
Exyte
Sponsors & Partners
Gold Sponsor
Gold Sponsor
Agenda at a Glance
Two intensive days spanning the full HPAPI value chain, from regulatory compliance and containment engineering to automation, sustainability and supply chain resilience.
23 more sessions across both days
Add your business email to unlock the full Rome 2027 programme, including every talk title and speaker slot.
We will send the PDF agenda across as well.
Drinks Reception
End of Day 1 from 17:30 informal, relationship-first networking
1:1 Meetings
Structured matchmaking with sponsors, speakers, and delegates
Networking Lunches
Shared lunches both days cross-industry connection opportunity
Sponsor Exhibition
Dedicated exhibition space running across both conference days
Two Editions. One Growing Community.
Milan 2026 in Two Minutes
The official highlights film from the 2nd Annual edition: two days of sessions, exhibition floor and networking, cut into a single reel.
Glimpses of Milan 2026
Real photographs from the 2nd Annual edition.
Why sponsor MaxPotent 2027
Sponsoring MaxPotent Pharma Summit places your brand at the centre of Europe's most focused HPAPI conference, with direct access to 300+ senior decision-makers you cannot reach anywhere else.
Speaking Access
Reserved branded speaking slot in the main programme (Platinum & Gold) 30 minutes on Day 1.
Exhibition Space
Dedicated 10×6ft stand for live product demos and direct delegate engagement across both days.
Delegate List
The full delegate list with profiles is sent to you ten days before the summit, so you choose exactly who you meet.
1:1 Matchmaking
Up to 10 pre-arranged one-to-one meetings with your most relevant delegates and prospects.
Brand Visibility
Logo placement across the website, programme brochure, email campaigns, and all on-site materials.
Reception & Branding
Drinks reception, conference bag, lanyard and refreshment sponsorships put your brand in front of every delegate.
What Sponsors and Delegates Say
The event was exceptionally well organised, offering ample networking opportunities with a large number of attendees and presenters. The hospitality was excellent, and it was a pleasure to interact with colleagues while highlighting the importance of toxicology in areas such as containment, risk assessment, and both worker and patient protection. We look forward to collaborating with Convolign on future events as well.
We truly felt we were at the right place. Over the past two days, we had insightful discussions around containment systems. The event brought together many customers, key manufacturers, and leading engineering companies, making it a great platform to exchange knowledge, information, and experience. We will definitely look forward to joining next year’s edition.
Congratulations to the entire team of Convolign Business Consulting for organising such a wonderful event. It was a perfect platform to gain insights into the key factors and technologies shaping high potent drug manufacturing. We also had excellent opportunities to network with peers and connect with new clients.
The event was highly informative, and we made some excellent industry contacts to introduce our systems to. The footfall was impressive, and the presentations were insightful. Overall, it was a great event for us, and we look forward to attending the next edition.
We had an excellent delegate turnout. The one-to-one meetings were very well organised and provided a great platform to connect with leaders from across various segments of HPAPI drug development. Truly a valuable opportunity for meaningful discussions and collaborations.
I found the event very engaging, with a wide range of interesting topics covered. The venue was excellent, offering plenty of opportunities for networking, and the hospitality was truly remarkable.
60+ Companies Represented to Date
A snapshot of the organisations that have joined the summit across its first two editions.
Why Rome for the Third Edition
The summit series moves to Rome for its third edition. Here is what that changes for the people travelling to it.
The first two editions proved the format in Milan, at the centre of Italy’s API manufacturing cluster. Rome widens the door. It is the best-connected city in Italy for international delegates, with two airports carrying direct flights from across Europe, the Americas and Asia, so the CDMO partners, regulators and technology providers who could not easily reach Milan can now attend without a connecting flight. Rome also puts the summit alongside the Lazio pharmaceutical corridor and within reach of the regulatory community, while offering the conference capacity and hotel choice that a growing delegation needs.
Two airports and high-speed rail
Fiumicino and Ciampino give delegates direct access from across Europe and beyond, both 30 to 45 minutes from the centre. Roma Termini reaches Milan in about three hours, with direct links to Florence, Bologna, Naples and Venice, so the summit combines easily with site visits.
One of Italy’s strongest pharma corridors
Rome sits alongside Lazio, one of the country’s densest concentrations of pharmaceutical manufacturing and contract development, with the containment and engineering specialists that serve it.
26 pharma manufacturers nearby
Latina province alone holds 12 manufacturers in Latina and 9 in Aprilia, with more across Sermoneta, Cisterna di Latina and Cori, all within reach of the summit.
150+ senior professionals in one place
20+ industry experts alongside them, for high-value conversations across HPAPI manufacturing, containment, compliance and CDMO partnerships.
Join Us in Rome
Venue to be announced
The 3rd Annual MaxPotent Pharma Summit takes place in Rome on 21–22 April 2027. The venue is being finalised. Full venue and accommodation details are shared with registered delegates and confirmed sponsors as soon as they are confirmed.
Italy, a European HPAPI heartland
Italy hosts one of Europe’s densest concentrations of API and HPAPI contract manufacturers, from Lombardy to Lazio, alongside the engineering and containment specialists that serve them. That is why the summit series has made Italy its home since the inaugural Milan edition.
Get in touch
with our team
For registration enquiries, speaking opportunities or sponsorship packages, our team is ready to assist.